SAPS-053 - Abortion medication availability in community pharmacies when mifepristone is regulated as a normally prescribed medication: a mystery caller study

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: SAPS-053
• By: PAMMETT, Robert (Department of Obstetrics & Gynaecology, McMaster University , Canada)
• Co-author(s): Elizabeth Nethery (Faculty of Pharmaceutical Sciences, University of British Columbia University Of British Columbia, Vancouver, Canada)
  Catherine Xu (Faculty of Pharmaceutical Sciences, University of British Columbia University Of British Columbia, Vancouver, Canada / Faculty of Medicine, University of British Columbia, Vancouver, Canada)
  Carissa Chan (Faculty of Pharmaceutical Sciences, University of British Columbia University Of British Columbia, Vancouver, Canada)
  Mary Helmer-Smith (Faculty of Pharmaceutical Sciences, University of British Columbia University Of British Columbia, Vancouver, Canada / Centre for Health Services and Policy Research, University of British Columbia , Vancouver, Canada)
  Andrea Stucchi (Faculty of Pharmaceutical Sciences, University of British Columbia University Of British Columbia, Vancouver, Canada / Centre for Health Services and Policy Research, University of British Columbia , Vancouver, Canada)
  Dawn Mooney (Centre for Health Services and Policy Research, University of British Columbia , Vancouver, Canada)
  Enav Zusman (Department of Obstetrics & Gynaecology, Faculty of Medicine, University of British Columbia, Vancouver, Canada)
  Sheila Dunn (Department of Family & Community Medicine, University of Toronto , Toronto, Canada / Women’s College Research Institute, Women’s College Hospital, Toronto, Canada)
  Mr Robert Pammett (Faculty of Pharmaceutical Sciences, University of British Columbia University Of British Columbia, Vancouver, Canada / Northern Health, Prince George, Canada)
  Wendy Norman (Faculty of Medicine, University of British Columbia, Vancouver, Canada / Department of Public Health, Environments and Society, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine , London, United Kingdom)
  Giuliana Guarna (Department of Obstetrics & Gynaecology, McMaster University , Hamilton, Canada)
  Michael Law (Centre for Health Services and Policy Research, University of British Columbia , Vancouver, Canada)
  Laura Schummers (Faculty of Pharmaceutical Sciences, University of British Columbia University Of British Columbia, Vancouver, Canada)
  
• Abstract:

  Introduction: Under a globally unprecedented model, the mifepristone-misoprostol medication abortion regimen became available in Canada as a normally prescribed medication, without restrictions, in 2018. Despite rapid uptake by prescribers, patients report difficulty accessing this time-sensitive medication. The purpose of this study was to..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login